We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$1.3B
AUM Growth
+$14.2M
Cap. Flow
-$34.3M
Cap. Flow %
-2.64%
Top 10 Hldgs %
40.52%
Holding
205
New
7
Increased
59
Reduced
90
Closed
11

Top Buys

Rank Stock Value
1
EMR icon
Emerson Electric
EMR
+$3.65M
2
UNH icon
UnitedHealth
UNH
+$2.1M
3
CMI icon
Cummins
CMI
+$1.94M
4
ADBE icon
Adobe
ADBE
+$1.57M
5
AMGN icon
Amgen
AMGN
+$1.46M

Top Sells

Rank Stock Value
1
PLD icon
Prologis
PLD
+$5.34M
2
CCI icon
Crown Castle
CCI
+$4.67M
3
WFC icon
Wells Fargo
WFC
+$4.4M
4
SPGI icon
S&P Global
SPGI
+$3.8M
5
BA icon
Boeing
BA
+$3.13M

Sector Composition

Rank Sector Weight
1 Consumer Staples 29.29%
2 Technology 13.68%
3 Healthcare 12.16%
4 Financials 11.31%
5 Industrials 7.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
26
Pfizer
PFE
$140B
$11M 0.85%
324,122
-3,010
-0.9% -$96.7K
GE icon
27
GE Aerospace
GE
$367B
$10.9M 0.84%
93,979
+2,170
+2% +$262K
USB icon
28
US Bancorp
USB
$99.6B
$10.6M 0.82%
198,602
-25,760
-11% -$1.35M
TXN icon
29
Texas Instruments
TXN
$255B
$10.6M 0.81%
118,000
-5,800
-5% -$477K
CVX icon
30
Chevron
CVX
$388B
$10.6M 0.81%
89,821
-7,000
-7% -$764K
TFC icon
31
Truist Financial
TFC
$63.2B
$10.6M 0.81%
224,773
+2,000
+0.9% +$91.9K
RTX icon
32
RTX Corp
RTX
$287B
$10.3M 0.79%
140,471
-2,677
-2% -$198K
SPGI icon
33
S&P Global
SPGI
$126B
$10.2M 0.78%
65,000
-25,000
-28% -$3.8M
AFL icon
34
Aflac
AFL
$63.9B
$10.1M 0.78%
248,600
-5,400
-2% -$217K
MXIM
35
DELISTED
Maxim Integrated Products
MXIM
$9.99M 0.77%
209,401
-5,100
-2% -$234K
DIS icon
36
Walt Disney
DIS
$165B
$9.8M 0.76%
99,471
+3,990
+4% +$410K
ORCL icon
37
Oracle
ORCL
$331B
$9.66M 0.74%
199,720
-19,430
-9% -$967K
CVS icon
38
CVS Health
CVS
$137B
$9.65M 0.74%
118,668
+3,498
+3% +$277K
JD icon
39
JD.com
JD
$40.8B
$9.55M 0.74%
249,900
-15,600
-6% -$668K
SPY icon
40
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$9.17M 0.71%
36,488
-3,148
-8% -$776K
CELG
41
DELISTED
Celgene Corp
CELG
$9.08M 0.7%
62,268
-2,050
-3% -$279K
MON
42
DELISTED
Monsanto Co
MON
$9.01M 0.69%
75,200
+60
+0.1% +$7.06K
BMY icon
43
Bristol-Myers Squibb
BMY
$127B
$8.17M 0.63%
128,196
-4,050
-3% -$236K
AXP icon
44
American Express
AXP
$223B
$8.07M 0.62%
89,227
+9,400
+12% +$808K
MDT icon
45
Medtronic
MDT
$107B
$8.06M 0.62%
103,586
-2,466
-2% -$205K
VZ icon
46
Verizon
VZ
$194B
$7.58M 0.58%
153,055
-2,260
-1% -$106K
UNH icon
47
UnitedHealth
UNH
$382B
$7.44M 0.57%
38,010
+10,885
+40% +$2.1M
PM icon
48
Philip Morris
PM
$301B
$7.23M 0.56%
65,096
-2,210
-3% -$257K
COF icon
49
Capital One
COF
$124B
$7.2M 0.55%
84,995
CL icon
50
Colgate-Palmolive
CL
$72.6B
$7.04M 0.54%
96,580
-710
-0.7% -$51.2K

Similar funds

Cullinan Associates's Q3 2017 Portfolio in Review

As of Q3 2017, Cullinan Associates held 205 positions worth $1.3B, up 1.1% from $1.28B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Cullinan Associates's Q3 2017 filing shows 7 new, 59 increased, 90 reduced and 11 closed positions. Its largest new stake was Brighthouse Financial: 7,135 shares worth $434K. The largest sale was Prologis, an estimated $5.34M.

By sector, the portfolio is most concentrated in Consumer Staples at 29% of assets, up from 29% a quarter earlier, followed by Technology and Healthcare.

  • Cullinan Associates's largest Q3 2017 buy was Brighthouse Financial: 7,135 shares worth $434K.
  • Cullinan Associates added most to Emerson Electric in Q3 2017, an estimated $3.65M increase.
  • Cullinan Associates's biggest Q3 2017 reduction was Prologis, cutting an estimated $5.34M.
  • Cullinan Associates fully exited Crown Castle in Q3 2017, selling an estimated $4.67M.
  • Cullinan Associates's ten largest holdings make up 41% of its $1.3B portfolio in Q3 2017.
  • Cullinan Associates opened 7 new positions and closed 11 in Q3 2017.
  • Cullinan Associates's portfolio value rose 1.1% quarter-over-quarter to $1.3B.

Based on Cullinan Associates's 13F filing for Q3 2017, filed 16 Oct 2017.